Literature DB >> 17138678

Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients.

M Dailloux1, M L Abalain, C Laurain, L Lebrun, C Loos-Ayav, A Lozniewski, J Maugein.   

Abstract

The incidence of nontuberculous mycobacteria (NTM) pulmonary diseases in HIV-negative patients was studied prospectively from January 1, 2001 to December 31, 2003 by 32 sentinel sites distributed throughout France. In total, 262 patients who yielded NTM isolates from respiratory clinical specimens, met the bacteriological, radiological and clinical criteria established by the American Thoracic Society for NTM respiratory disease. Among the 262 NTM isolates, 234 were slow-growing mycobacteria (125 Mycobacterium avium-intracellulare complex (MAC), 66 M. xenopi, 34 M. kansasii) and 28 were rapidly growing mycobacteria (25 M. abscessus complex). In the Paris area, M. xenopi was the most frequently isolated species, followed by MAC. Most patients (>50%), except those with M. kansasii, had underlying predisposing factors such as pre-existing pulmonary disease or immune deficiency. Asthenia, weight loss, chronic cough and dyspnoea were the most common clinical symptoms. The classical radiological appearance of NTM infections was indistinguishable from that observed in patients with pulmonary tuberculosis. In summary, the incidence of nontuberculous mycobacteria pulmonary infections in HIV-negative patients was estimated at 0.74, 0.73 and 0.72 cases per 100,000 inhabitants in 2001, 2002 and 2003, respectively.

Entities:  

Mesh:

Year:  2006        PMID: 17138678     DOI: 10.1183/09031936.00063806

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  38 in total

Review 1.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

2.  Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.

Authors:  Aurélie Renvoisé; Christine Bernard; Nicolas Veziris; Eve Galati; Vincent Jarlier; Jérôme Robert
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

3.  Effect of amikacin on cell wall glycopeptidolipid synthesis in Mycobacterium abscessus.

Authors:  So-Young Lee; Hee-Youn Kim; Byoung-Jun Kim; Hong Kim; Seung-Hyeok Seok; Bum-Joon Kim; Yoon-Hoh Kook
Journal:  J Microbiol       Date:  2017-07-28       Impact factor: 3.422

4.  Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics.

Authors:  Theodore K Marras; Mauli Mehta; Pamela Chedore; Kevin May; Mohammed Al Houqani; Frances Jamieson
Journal:  Lung       Date:  2010-04-11       Impact factor: 2.584

5.  Mycobacterium intracellulare infection in non-HIV infected patient in a region with a high burden of tuberculosis.

Authors:  Fredrick Haraka; Liliana Kokusanilwa Rutaihwa; Manuel Battegay; Klaus Reither
Journal:  BMJ Case Rep       Date:  2012-05-08

6.  High-resolution CT of nontuberculous mycobacteria pulmonary infection in immunocompetent, non-HIV-positive patients.

Authors:  R Polverosi; A Guarise; E Balestro; A Carloni; G Dalpiaz; B Feragalli
Journal:  Radiol Med       Date:  2009-12-14       Impact factor: 3.469

7.  Nontuberculous mycobacterial infections among patients suspected of pulmonary tuberculosis.

Authors:  H Grubek-Jaworska; R Walkiewicz; A Safianowska; M Nowacka-Mazurek; R Krenke; T Przybyłowski; R Chazan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-14       Impact factor: 3.267

8.  Variable-number tandem-repeat markers for typing Mycobacterium intracellulare strains isolated in humans.

Authors:  Frédéric-Antoine Dauchy; Sébastien Dégrange; Alain Charron; Michel Dupon; Yi Xin; Cécile Bébéar; Jeanne Maugein
Journal:  BMC Microbiol       Date:  2010-03-29       Impact factor: 3.605

9.  Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.

Authors:  Nathalie Coolen-Allou; Thomas Touron; Olivier Belmonte; Virgile Gazaille; Michel Andre; Jérôme Allyn; Sandrine Picot; Annabelle Payet; Nicolas Veziris
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

10.  Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

Authors:  Anne-Laure Roux; Emilie Catherinot; Fabienne Ripoll; Nathalie Soismier; Edouard Macheras; Sophie Ravilly; Gil Bellis; Marie-Anne Vibet; Evelyne Le Roux; Lydie Lemonnier; Cristina Gutierrez; Véronique Vincent; Brigitte Fauroux; Martin Rottman; Didier Guillemot; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.